Gubra
483.20 DKK
+1.13 %
Less than 1K followers
GUBRA
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
+1.13 %
+13.00 %
+22.27 %
+4.82 %
-22.56 %
-28.94 %
-
-
+339.27 %
Gubra is a pharmaceutical company. The company's operations are focused on the early stages of drug development. They primarily conduct research and development in the area of metabolic and fibrotic diseases. The company's product portfolio includes several brands and drugs, and the operations are conducted on a global level, with the largest presence in North America and the Nordic region. The headquarters are located in Hørsholm, Denmark.
Read moreMarket cap
7.9B DKK
Turnover
7.57M DKK
Revenue
265.74M
EBIT %
-18.82 %
P/E
-
Dividend yield-%
12.67 %
Latest research
Latest analysis report
Released: 2025-03-17
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
27/2
2026
Annual report '25
All
Research
Webcasts
Press releases
ShowingAll content types
Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares
Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
